Clinical Trial Update: Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the effect of methyldopa on uterine artery diameter in pregnant women with mild preeclampsia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Methyldopa (methyldopa)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Pregnant Women With Mild Preeclampsia | Phase 2 | Status: COMPLETED